- Country: USA
- Summary: Targeting Inflammasomes In Hiv And Substance Use (R21 Clinical Trial Not Allowed)
- UST Ref No: 109437580
- Deadline: 13 Mar 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: RFA-DA-25-068
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The Scientific Objective Of This Notice Of Funding Opportunity Is To Encourage Research To Delineate The Role Of Inflammasomes In The Neuropathology Produced By Acute Or Chronic Drug Exposure And Hiv Infection. Understanding The Involvement Of Inflammasomes In Virus And Drug-Induced Immune Activation May Help Identify Molecular Markers And Cns Immune Cells Associated With Hiv-1 Infection Or Disease Progression Among Substance Abuse Populations, As Well As Identify Novel Therapies To Target Inflammasome Activation Or Suppression To Treat Neuroinflammation And Immune Dysregulation Aroused In These Processes.
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINTargeting Inflammasomes In Hiv And Substance Use (R21 Clinical Trial Not Allowed) - USA Tender
The NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Targeting Inflammasomes In Hiv And Substance Use (R21 Clinical Trial Not Allowed). This tender is published on USARFP under UST Ref No: 109437580 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-03-13.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
